ORPRO THERAPEUTICS
OrPro Therapeutics,Inc. is a pre-clinical stage biopharmaceutical company headquartered in San Diego, CA. The company’s goal is to develop a breakthrough class of safe, well-tolerated and effective inhaled non-systemic drugs based on the thioredoxin active site for the treatment of patients with cystic fibrosis (CF) and other serious obstructive pulmonary diseases.
ORPRO THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.orprotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
858-242-1557
Total Funding:
4.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Peter Heifetz CEO @ Orpro Therapeutics
CEO
2011-02-01
Jeff Raser COO @ Orpro Therapeutics
COO
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Orpro Therapeutics
Official Site Inspections
http://www.orprotherapeutics.com
- Host name: 103.4.180.107.host.secureserver.net
- IP address: 107.180.4.103
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Orpro Therapeutics"
About Us – OrPro Therapeutics, Inc.
OrPro Therapeutics, Inc (San Diego, CA) OrPro Therapeutics, Inc. (San Diego, CA) is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for treatment …See details»
Orpro Therapeutics - Crunchbase Company Profile & Funding
OrPro Therapeutics,Inc. is a pre-clinical stage biopharmaceutical company headquartered in San Diego, CA. The company’s goal is to develop a breakthrough class of safe, well-tolerated and …See details»
OrPro Therapeutics, Inc.
OrPro Therapeutics is developing ORP100S, a novel biologic therapy to treat inflammation and obstruction in the lung associated with both chronic airway disorders and progression to …See details»
Orpro Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orpro Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Management Team – OrPro Therapeutics, Inc.
Marie Jacqueline (Jacki) Johnson, Ph.D. is a seasoned entrepreneur with over 30 years experience in the biotechnology industry. She was a founder of biotechnology companies …See details»
OrPro Therapeutics Company Profile | Management and
Www.orprotherapeutics.com OrPro Therapeutics Profile and History OrPro Therapeutics, Inc. (San Diego, CA) is a privately-held preclinical-stage company developing a non-systemic biologic …See details»
Orpro Therapeutics - LinkedIn
OrPro Therapeutics, Inc. is a San Diego preclinical-stage Johnson & Johnson JLABS alumni company addressing large unmet medical needs in acute and chronic respiratory, …See details»
Orpro Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Orpro Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
OrPro Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore OrPro Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Drug:ORP-100.See details»
ORPRO THERAPEUTICS, INC. - VentureRadar
OrPro Therapeutics is a privately-held preclinical-stage company developing a non-systemic biologic drug platform for treatment of diseases of the... ... Find out ...See details»
OrPro Therapeutics - PitchBook
OrPro Therapeutics General Information Description. Developer of modified recombinant thioredoxin designed to treat obstructive and inflammatory disease. The company's technology …See details»
Orpro Therapeutics Overview | SignalHire Company Profile
Organization Website: orprotherapeutics.com : Orpro Therapeutics industries Biotech: Headquarters Location: 3210 Merryfield Row, SAN DIEGO, CA, 92121 US 3210 Merryfield …See details»
OrPro Therapeutics, Inc.:Company Profile & Technical Research ...
OrPro Therapeutics, Inc. is a company that provides Thioredoxin, Medicine, Pharmacy and Therapeutics and more. OrPro Therapeutics, Inc. is headquartered in United States California.See details»
OrPro Therapeutics - Overview, News & Similar companies
May 28, 2020 View OrPro Therapeutics (www.orprotherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
OrPro Therapeutics Summary - Craft
OrPro Therapeutics has 5 employees at their 1 location and $2.3 m in total funding,. See insights on OrPro Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
OrPro Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 3210 Merryfield Row . San Diego, California, 92121, United States. 858-242-1557See details»
OrPro Therapeutics Inc Overview - Salary.com
Discover essential details about OrPro Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Board of Directors – OrPro Therapeutics, Inc.
Mr. James A. Weil has been the president of INSL-X Products Corporation since 1979 and consults for NY Fuel Distributors, LLC. In addition to OrPro he also serves as a board director …See details»
ORP-100 - Drug Targets, Indications, Patents - Synapse - Patsnap
Active Organization-Inactive Organization. OrPro Therapeutics, Inc. Drug Highest Phase Pending Preclinical. First Approval Date-Regulation- ... For more information visit …See details»
Abera and Orexo partner for vaccine powder formulations
2 days ago The partnership aims to develop powder formulations of the vaccine candidates against influenza by leveraging Orexo’s AmorphOX technology. Credit: Ground …See details»